Company Description
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes.
The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services.
It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D.
The company’s platform includes Automated Insulin Delivery (AID) systems for glucose sensing and automated insulin dosing and administration for glycemic control and Smart Multiple Daily Injection (MDI) systems for self-administering insulin by manual injections, which include InPen, Simplera Sync, or Guardian 4 sensor, and wraparound applications and services.
It also offers CareLink, a software platform that provides support for person with diabetes, their caretakers, and HCPS.
MiniMed Group, Inc. was founded in 1983 and is headquartered in Northridge, California. MiniMed Group, Inc. operates as a subsidiary of Medtronic plc.
| Country | United States |
| Founded | 1983 |
| IPO Date | Mar 6, 2026 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 8,000 |
| CEO | Que Dallara |
Contact Details
Address: 18000 Devonshire Street Northridge, California 91325 United States | |
| Phone | 763 514 4000 |
| Website | minimed.com |
Stock Details
| Ticker Symbol | MMED |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| IPO Price | $20.00 |
| CIK Code | 2062583 |
| CUSIP Number | 60365F109 |
| ISIN Number | US60365F1093 |
| Employer ID | 33-3985981 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Que Thanh Dallara | Chief Executive Officer and Director |
| Ali Dianaty | Executive Vice President and Chief Product and Technology Officer |
| Courtney Nelson Wills | SVice President, General Counsel and Corporate Secretary |
| Gillian Chandrasena | Senior Vice President and Chief Human Resources Officer |
| Christopher E. Eso | President |
| Chad J. Spooner | Executive Vice President and Chief Financial Officer |
| John Gyurci | Vice President, Chief Accounting Officer and Controller |
| Mike Bruggeman | SVice President and Chief Information Officer |
| Ryan Weispfenning | Head of Investor Relations |
| Kate Cronin MSN RN | SVice President and Chief Marketing Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 29, 2026 | 10-K | Annual Report |
| Jun 29, 2026 | 8-K | Current Report |
| Jun 3, 2026 | 8-K | Current Report |
| May 18, 2026 | 8-K | Current Report |
| May 6, 2026 | SCHEDULE 13G | Filing |
| Apr 27, 2026 | 8-K | Current Report |
| Apr 17, 2026 | 10-Q | Quarterly Report |
| Mar 27, 2026 | 8-K | Current Report |
| Mar 25, 2026 | 8-K | Current Report |
| Mar 9, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |